serum hexose

Glycogen also belongs to a polysaccharide, but it consists only of glucose. In addition, a small amount of fructose, lactose, xylose, hexose, etc. are present in the human body. Increase liver cirrhosis and chronic hepatitis. The glycosaminoglyase is the main protease that breaks down the sugar in the human body. When the body suffers from diseases such as kidney disease or diabetes, the content of glycosidase in the blood will change, which will lead to sugar in the urine. The content also changes. Basic Information Specialist classification: cardiovascular examination classification: biochemical examination Applicable gender: whether men and women apply fasting: not fasting Tips: After 8 pm on the day before the medical examination, you should fast, so as not to affect the detection of indicators such as blood glucose in the second sky. Normal value (1) Customary units: 1 serum: Non-carrier: 90 ~ 289μg / L. Specific carrier: 77 ~ 164μg / L. (Parents of Tessa children) Carrier: 77 ~ 224μg / L. Tessa patients: 90 ~ 116μg / L. 2 platelets: Non-carrier: 272 ~ 795nmol · h-1 · ml-1. Carrier: 226 ~ 798nmol · h-1 · ml-1. 3 amniotic fluid fibroblasts: Non-carrier: 1600 nmol·h-1·mg protein-1. Hybrid fetus: 1320 nmol·h-1·mg protein-1. Teratal fetus: 860 nmol·h-1·mg protein-1. 4 urine: 3.85 ± 2.3 U / L. 5 lymphocytes. Normal undifferentiated lymphocytes: 9.7 to 52.0 nmol·h-1·103 cells-1. Normally highly differentiated T lymphocytes: 9.1 to 32.1 nmol·h-1·103 cells-1. Normally highly differentiated B lymphocytes: 22.6 to 61.0 nmol·h-1·103 cells-1. (2) Legal unit: 1 serum: the same as the customary unit. 2 platelets: Non-carrier: 4.53 ~ 13.28U / L. Carrier: 3.77 ~ 13.30U / L. 3 amniotic fluid fibroblasts: Non-carrier: 26.67kU/kg protein. Hybrid fetus: 22.00 kU/kg protein. Tessa fetus: 14.33kU/kg protein. 4 urine: 3.8 ± 2.3 U / L (± s). 5 lymphocytes: Normal undifferentiated lymphocytes: 0.16 to 0.87 nU/cell. Normally well differentiated T lymphocytes: 0.15 to 0.54 nU/cell. Normally well differentiated B lymphocytes: 0.38 to 1.02 nU/cell. Clinical significance (1) serum has increased glycosamine total enzyme: diabetes, pregnancy; serum hexosamine total enzyme decline: Sandhoff disease. (2) Platelet glucosamine total enzyme decline: pregnancy, insulin-dependent diabetes. (3) Increased glucosamine total enzyme in urine: nephrotic syndrome, acute renal transplant rejection, urinary tract infection, acute tubular necrosis, acute glomerulonephritis, chronic pyelonephritis, rheumatoid arthritis, bypass surgery, burns . (4) Lymphocyte hexosamine total enzyme decline: chronic lymphocytic leukemia. Low results may be diseases: pregnancy with diabetes, acute glomerulonephritis results may be high disease: nephrotic syndrome precautions (1) Rate method measurement (taking a semi-automatic analyzer as an example): The specificity of the glycosylated kinase method is higher than that of the glucose oxidase method, and is currently a reference method for measuring blood glucose, and is suitable for use in an automatic analyzer. Mild hemolysis, lipemia, jaundice, vitamin C, sodium fluoride, heparin, EDTA and oxalate do not interfere with this method. Because the organic phosphates and some enzymes released from red blood cells can consume NADP, they interfere with this method. Inspection process Rate method determination (taking a semi-automatic analyzer as an example): 1 main parameters: Coefficient: 8.2. Incubation time: 30 s. Monitoring time: 60s. Wavelength: 340 nm. Aspirate amount: 0.5 ml. Temperature: 37 ° C. 2 Loading: 1000 μl of pre-warming enzyme mixing reagent at 37 ° C, adding 20 μl of serum, and immediately inhaling an automatic analyzer to monitor the rate of increase in absorbance (ΔA/min). Not suitable for the crowd 1. Patients who have taken contraceptives, thyroid hormones, steroid hormones, etc., may affect the results of the examination and prohibit patients who have recently taken the drug history. 2, special diseases: patients with hematopoietic function to reduce disease, such as leukemia, various anemia, myelodysplastic syndrome, etc., unless the examination is essential, try to draw less blood. Adverse reactions and risks 1, subcutaneous hemorrhage: due to pressing time less than 5 minutes or blood draw technology is not enough, etc. can cause subcutaneous bleeding. 2, discomfort: the puncture site may appear pain, swelling, tenderness, subcutaneous ecchymosis visible to the naked eye. 3, dizzy or fainting: in the blood draw, due to emotional overstress, fear, reflex caused by vagus nerve excitement, blood pressure decreased, etc. caused by insufficient blood supply to the brain caused by fainting or dizziness.

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.